By tailoring treatment to each patients unique needs, we make care more personal, accessible, and effective leading to stronger long-term health outcomes
Finally, if brain fog coincides with dose escalation, discussing a slower titration schedule with your PlexusDx clinician may reduce the intensity of adjustment symptoms while maintaining safety and efficacy
Cholesterol mediated ferroptosis suppression reveals essential roles of Coenzyme Q and squalene
Other At-Risk Groups GLP-1 medications are generally not suitable for individuals with severe gastrointestinal disorders like gastroparesis, those with type 1 diabetes (as these drugs are approved only for type 2 diabetes and obesity), and people with a history of suicidal thoughts, active eating disorders, or heavy alcohol use
This enhanced monitoring is indicated by a black triangle () symbol in the product literature, though clinicians should check the current SmPC to confirm the monitoring status
Lancet Diabetes Endocrinol 8:535545